930
Participants
Start Date
December 31, 2025
Primary Completion Date
September 30, 2026
Study Completion Date
September 30, 2026
HeartCare
Using HeartCare platform as a tool to successfully augment immunosuppressant agents through regular surveillance allowing minimization of doses and number of agents.
Lead Sponsor
CareDx
INDUSTRY